Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization.

Source:http://linkedlifedata.com/resource/pubmed/id/11914269

Circulation 2002 Mar 26 105 12 e74

Download in:

View as

Triples

General Info

PMID
11914269